Muna Drweesh Horabi

Dr. Muna Drweesh Horabi


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
DZDalia Kashef Zayed
Dalia Kashef Zayed
SMSalam Momani
Salam Momani
Muna Drweesh HorabiMuna Drweesh Horabi
Muna Drweesh Horabi
AAAlaa Alquran
Alaa Alquran
FAFurat K. Al-Nawaiseh
Furat K. Al-Nawaiseh
Ala'a B. Al-Tammemi, MD, MPHAla'a B. Al-Tammemi, MD, MPH
Ala'a B. Al-Tammemi, MD, MPH
Background: Mapping policies, strategies, and legislations related to disease prevention in Jordan is pivotal for strengthening the country’s public health infrastructure. The aims of our study were to identify, review, and map the existing national policies, strategies, and legislations related to the One Health approach to zoonoses, antimicrobial stewardship (AMS), and climate change in Jordan. Additionally, we identified the key strengths and major gaps and uncovered opportunities for enhancement. The current paper reports a part of a nationwide project which was jointly executed in 2023 by the Jordan Center for Disease Control and the Health Care Accreditation Council. Methods: A multimethod approach was employed, including a comprehensive desk review of any existing policies, strategies, and legislations, along with key informant interviews involving key stakeholders. The combination of the desk review and key informant interviews allowed for a more nuanced understanding of the gaps, strengths, and challenges in Jordan’s approach to One Health, AMS, and climate change adaptation. By triangulating the findings from both methods, the study was able to cross-validate its results and ensure greater reliability and accuracy in its conclusions. Results: Our analyses revealed that Jordan has made notable progress in integrating the One Health approach within its regulatory framework, particularly in managing zoonotic diseases, AMS, and climate change. Nevertheless, there is a need for more explicit and effective intersectoral coordination. While the country’s AMS initiatives are supported by a national action plan, they are limited by inadequate public awareness, veterinary regulations, and monitoring systems. Moreover, Jordan’s climate change strategies, aligned with broader sustainability goals and integrated into national frameworks like the environmental protection law, are constrained by a lack of emergency preparedness and multisectoral collaboration. The SWOT analysis highlighted strengths, including robust legal structures and international collaborations, while identifying gaps in enforcement and the need for updated guidelines. Opportunities exist to enhance the reporting mechanisms, public awareness, and international partnerships. Conclusions: Jordan’s integration of the One Health approach to zoonotic diseases, AMS, and climate change adaptation into its disease prevention policies is commendable and aligns with global health priorities. To further enhance these initiatives, Jordan could benefit from updating its public health law and the relevant guidelines and policies, strengthening and structuring public awareness campaigns, and developing detailed climate change adaptation strategies.

14 October 2025 in Journal of Molecular Histology
Verified
Journal Article
Closed access
PDF file
KAKhaled Abdul-Aziz Ahmed
Khaled Abdul-Aziz Ahmed
KAKhalid M. Alqaisi
Khalid M. Alqaisi
NINoralhuda Ayad Ibrahim
Noralhuda Ayad Ibrahim
Najat Jabbar AhmedNajat Jabbar Ahmed
Najat Jabbar Ahmed
QAQosay Al-Balas
Qosay Al-Balas
TATalal Al-Qaisi
Talal Al-Qaisi

23 May 2025 in Science in One Health
Verified
Journal Article
Open access
Ala'a B. Al-Tammemi, MD, MPHAla'a B. Al-Tammemi, MD, MPH
Ala'a B. Al-Tammemi, MD, MPH
SMSalam Momani
Salam Momani
Hanan HasanHanan Hasan
Hanan Hasan
AOAmal Obeidat
Amal Obeidat
Muna Drweesh HorabiMuna Drweesh Horabi
Muna Drweesh Horabi
Antimicrobial resistance (AMR) has emerged as a critical public health threat and one of the most complicated global challenges due to its multi-faceted nature. In addition to health burden, AMR also drives up healthcare costs and imposes substantial indirect economic impacts. Despite the ongoing global efforts, the burden of drug-resistant infections is still growing and alarming. Although AMR has been well addressed pertaining to human health, AMR linked to pathogens in other pillars of the food chain has been a hidden menace and a growing public health concern. AMR may arise in the food chain through various pathways, with foodborne drug-resistant pathogens being reported in the literature. Tackling and combatting AMR in the food chain requires a multi-faceted comprehensive approach under the One Health umbrella. This approach is crucial not only to protect public health but also to ensure the sustainability and safety of all components of the food chain.

DZDalia Kashef Zayed
Dalia Kashef Zayed
RARuba A. Al-Smadi
Ruba A. Al-Smadi
MAMohammad Zakareya Almaayteh
Mohammad Zakareya Almaayteh
TAThekryat Al-Hjouj
Thekryat Al-Hjouj
OHOla Hamdan
Ola Hamdan
Ala'a B. Al-Tammemi, MD, MPHAla'a B. Al-Tammemi, MD, MPH
Ala'a B. Al-Tammemi, MD, MPH
Infectious diseases remain a global threat, with low- and middle-income countries disproportionately affected due to socio-economic and demographic vulnerabilities. Robust laboratory systems are critical for early detection, outbreak containment, and guiding effective interventions. This study aimed to map and evaluate Jordan’s laboratory diagnostic network for communicable diseases, identify gaps, and recommend strategies to strengthen capacity, harmonization, and alignment with international standards. A multi-method approach was employed in 2023 through collaboration between the Jordan Center for Disease Control and the Health Care Accreditation Council. Data were collected via (i) a desktop review of 226 national and international documents; (ii) 20 key informant interviews with stakeholders from the public, private, military, veterinary, and academic sectors; and (iii) 23 field visits across 27 laboratories in four Jordanian governorates. Data were analyzed thematically and synthesized using the LABNET framework, which outlined ten core laboratory capacities. Findings were validated through a multi-sectoral national workshop with 90 participants. The mapping revealed the absence of a unified national laboratory strategic plan, with governance dispersed across multiple authorities and limited inter-sectoral coordination. Standard operating protocols (SOPs) existed for high-priority diseases such as T.B, HIV, influenza, and COVID-19 but were lacking or outdated for other notifiable diseases, particularly zoonoses. Quality management was inconsistent, with limited participation in external quality assurance programs and minimal accreditation uptake. Biosafety and biosecurity frameworks were fragmented and insufficiently enforced, while workforce shortages, high turnover, and limited specialized training constrained laboratory performance. Despite these challenges, Jordan demonstrated strengths including skilled laboratory staff, established reference centers, and international collaborations, which provide a platform for improvement. Jordan’s laboratory network has foundational strengths but faces systemic challenges in policy coherence, standardization, quality assurance, and workforce capacity. Addressing these gaps requires the development of a national laboratory strategic plan, strengthened legal and regulatory frameworks, enhanced quality management and accreditation, and integrated One Health coordination across human, animal, and environmental health sectors. These measures will improve diagnostic reliability, preparedness, and alignment with the global health security agenda.